-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Srixon Announces Buy 2, Get 1 Free Golf Ball Promotion
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
-
Who Is the Best Spanish-Speaking Private Investigator in Sacramento?
-
Healixa Turns Patents Into Products: FrostPulse(TM) Delivered and Five Eternal Spring(TM) Units Enter Production
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
-
Nearly Half of Transformation Initiatives Face a 'Momentum Gap' That Puts Value at Risk, NSP & Company Study Finds
-
CXAI Expands Agentic AI Reach into Mid-Market Through EngineRoom's Simpro Partnership
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Agency Guacamole's 10th B.L.N.D. Event Brought Industry Leaders Together for a Conversation on the Evolution of Diversity and Inclusion in Beauty
-
From Pilot to Production: InHand Networks' Practical Approach to Industrial Edge AI
WHO chief urges stronger Ebola response in DR Congo visit
The head of the World Health Organization on Wednesday urged authorities to step up the Ebola response and better protect frontline health workers, during a visit to the DR Congo where a deadly outbreak is spreading fast.
The Democratic Republic of Congo declared its 17th Ebola outbreak on May 15.
There have been 3,874 confirmed cases including 1,751 deaths in the DRC in the outbreak, according to figures published by the WHO.
WHO director-general Tedros Adhanom Ghebreyesus arrived in Kinshasa on Tuesday, and was set to meet President Felix Tshisekedi, a spokesman told AFP on Wednesday, without giving further details.
"The outbreak is spreading faster than our scale-up of the response, with new cases doubling in some hotspots over the past week alone," Tedros wrote on X, after meeting organisations involved in the response effort.
"We must urgently and massively scale up all our efforts.
"That means reaching every affected community despite insecurity and displacement, strengthening coordination... ensuring health workers have the protection, training and support they need, and accelerating access to care, surveillance and safe, dignified burials."
- US funding boost -
The United States announced Wednesday that it had allocated more than $242 million in additional funding to combat the worsening outbreak.
The new funding brings direct US financial assistance in response to the outbreak to more than $500 million, the State Department said, underlining that the United States remained "the largest financial contributor to the Ebola response".
Tedros was previously in the DRC at the end of May in the northeastern province of Ituri, where nearly 90 percent of Ebola cases have been identified.
The five affected provinces in eastern DRC have a weak state presence and healthcare infrastructure is largely lacking.
The struggle to contain the outbreak was laid bare this week in the Ituri mining town of Mongbwalu, where staff at an Ebola treatment centre protested over unpaid government allowances before being dispersed by police warning shots, according to hospital sources.
On Tuesday, a new 100-bed Ebola treatment centre opened in Ituri's capital Bunia, to help address the growing number of patients, the UN aid agency OCHA said.
Ebola is spread by contact with bodily fluids and causes a haemorrhagic fever. It has killed more than 15,000 people in Africa in the last 50 years.
- Vaccines and treatments -
The current outbreak has been caused by the Bundibugyo species of the virus, for which there is currently no approved vaccine or treatment.
On Tuesday, Canada gave the go-ahead to US pharmaceutical giant Moderna to begin clinical trials of a candidate vaccine against Bundibugyo.
In late July, a volunteer received the first dose of another potential vaccine against Bundibugyo, developed by Britain's Oxford University using the same technology as the AstraZeneca Covid-19 vaccine.
And Singapore-based Hilleman Laboratories is working on bringing a third potential Bundibugyo jab to human trials.
The WHO sees it as the "most promising" because it uses the same rVSV platform as the only officially licenced Ebola vaccine Ervebo, which targets a different strain called Zaire.
Two potential treatments are being tested on confirmed Ebola patients in Ituri: the monoclonal antibody MBP134 and the antiviral drug remdesivir, alone and in combination.
Meanwhile a trial is also taking place in Ituri of the oral antiviral drug obeldesivir, for people exposed to confirmed Bundibugyo cases.
K.Hill--AT